Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DDTL | 22.42 | 0.12 | +0.56% |
| Innovator Eq Dual Drctnl 10 Buf ETF -Jul | |||
| EFT | 10.59 | 0.02 | +0.19% |
| Eaton Vance Floating-Rate Income Trust | |||
| QTAP | 52.49 | N/A | N/A |
| Innovator Growth-100 Acltd Ps ETF™ April | |||
| EBI | 65.35 | N/A | N/A |
| The RBB Fund Trust Longview Advantage ETF | |||
| COMT | 37.53 | -0.55 | -1.44% |
| iShares GSCI Cmd Dyn Roll Stgy ETF | |||
A.I.dvisor indicates that over the last year, SEPN has been loosely correlated with KURA. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if SEPN jumps, then KURA could also see price increases.
| Ticker / NAME | Correlation To SEPN | 1D Price Change % | ||
|---|---|---|---|---|
| SEPN | 100% | +2.01% | ||
| KURA - SEPN | 38% Loosely correlated | -1.56% | ||
| RYTM - SEPN | 37% Loosely correlated | +2.46% | ||
| PCVX - SEPN | 37% Loosely correlated | +0.97% | ||
| TSHA - SEPN | 36% Loosely correlated | -2.71% | ||
| EWTX - SEPN | 36% Loosely correlated | +3.50% | ||
More | ||||
The 10-day RSI Oscillator for SEPN moved out of overbought territory on August 13, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 18 instances where the indicator moved out of the overbought zone. In 15 of the 18 cases the stock moved lower in the days that followed. This puts the odds of a move down at 83%.
The Momentum Indicator moved below the 0 level on August 25, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SEPN as a result. In 20 of 27 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 74%.
The Moving Average Convergence Divergence Histogram (MACD) for SEPN turned negative on August 21, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 9 similar instances when the indicator turned negative. In 5 of the 9 cases the stock turned lower in the days that followed. This puts the odds of success at 56%.
The 10-day moving average for SEPN crossed bearishly below the 50-day moving average on September 11, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 2 of 4 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 50%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SEPN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
SEPN broke above its upper Bollinger Band on August 11, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 19 of 21 cases where SEPN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
SEPN moved above its 50-day moving average on September 09, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.32% 3-day Advance, the price is estimated to grow further. Considering data from situations where SEPN advanced for three days, in 85 of 93 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
The Aroon Indicator entered an Uptrend today. In 100 of 112 cases where SEPN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 89%.
The Tickeron Valuation Rating of 37 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.649) is normal, around the industry mean (19.994). P/E Ratio (0.000) is within average values for comparable stocks, (27.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.527). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (17.391) is also within normal values, averaging (427.627).
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. SEPN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SEPN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.